
Bioventus Email Format
Medical Equipment Manufacturing
・
1,001-2,500 employees
・
Durham, NC, USA
Bioventus is a medical equipment manufacturing company that develops innovations for active healing, offering pain treatment, restorative therapies, and surgical solutions to patients worldwide.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@bioventus.com
Company Overview
Industry
Medical Equipment Manufacturing
Founded
2012
Headquarters
Durham, NC, USA
Revenue
$500M-$1B
FUNDING Stage
Public
Website
Key Executives
Robert Claypoole (Chief Executive Officer), Mark Singleton (Senior Vice President, Chief Financial Officer and Principal Accounting Officer), Keith McBride (Chief Technology Officer Vice President of R&D Pain and Restorative Therapies)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Bioventus?
Bioventus uses the first.last format, so Jane Smith would be jane.smith@bioventus.com.
What are the three main business segments that Bioventus organizes its products around?
Bioventus organizes its product portfolio around three segments: Pain Treatments, Restorative Therapies, and Surgical Solutions. Each segment targets distinct orthopedic needs, from osteoarthritis pain relief and peripheral nerve stimulation to bone graft substitutes and therapeutic ultrasonic technologies.
How many countries does Bioventus operate in?
Bioventus operates in more than 50 countries, giving the company a broad international footprint alongside its core U.S. business. Tools like Clay can help you identify and reach the right Bioventus contacts across those global markets.
Who is the CEO of Bioventus?
Robert Claypoole serves as the Chief Executive Officer of Bioventus. The company's leadership team also includes Mark Singleton as CFO and Keith McBride as Chief Technology Officer overseeing R&D for Pain and Restorative Therapies.
Does Bioventus offer platelet-rich plasma therapies as part of its product line?
Yes, Bioventus offers platelet-rich plasma therapies as part of its Pain Treatments and Joint Preservation segment. PRP is one of the key growth areas the company has committed to investing in through 2026, alongside peripheral nerve stimulation and ultrasonics.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating


